feed,title,long_url,short_url
Benzinga,"After Disappointing Data, Allakos Discontinues Work On Lirentelimab In Eosinophilic Gastrointestinal Diseases",https://benzinga.com/general/biotech/22/09/28809208/after-disappointing-data-allakos-discontinues-work-on-lirentelimab-in-eosinophilic-gastrointestin,https://bit.ly/3Bvryq9
